Treatment of pemphigus with intravenous immunoglobulin;Immunoglobulines intraveineuses dans le traitement du pemphigus

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 11, 2004, Pages 957-961

  Levy, A ^a   Doutre, M S ^b,e   Lesage, F X ^c   Richard, M A ^d,e   Picard Dahan, C ^a,e   Beylot Barry, M ^b   Bernard, P ^c,e   Crickx, B ^a   Descamps, V ^a  

^a BICHAT HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e Grp Bulles Soc Francaise Dermatol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOCHRYSINE; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DERMATOLOGY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEDICAL SOCIETY; PATIENT INFORMATION; PEMPHIGUS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SIDE EFFECT; STANDARDIZATION; TREATMENT OUTCOME;

EID: 10644295663     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93805-7     Document Type: Article

References (25)

1. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfert of IgG from patients with the disease. N Engl J Med 1982;306:1189-96.
2. Herbst A, Brystyn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000;42:422-7.
3. Jolies S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2001;26:127-31.
4. loannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 2000;136:868-72.
5. Jolles S, Hughes J, Rustin M. Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris. J Am Acad Dermatol 1999;40:499-500.
6. Tappeiner G, Steiner A. High dosage intravenous gammaglobulins: therapeutic failure in pemphigus and pemphigoid. J Am Acad Dermatol 1989;20:684-5.
7. Jolles S. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders. Clin Exp Immunol 2002;129:385-9.
8. Sami N, Qureshi A, Ruocco E, Ahmed AR. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol 2002;138:1158-62.
9. Sami N, Qureshi A, Ahmed AR. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus. Eur J Dermatol 2002;12:174-8.
10. Ahmed AR, Sami N. Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy. J Am Acad Dermatol 2002;46:42-9.
11. Ahmed AR. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001;45:679-90.
12. Bystryn JC, Jiao D, Natow S. Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol 2002;47:358-63.
13. Engineer L, Bhol KC, Ahmed AR. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris. J Am Acad Dermatol 2000;43:1049-57.
14. Sibaud V, Beylot-Barry M, Doutre MS, Beylot C. Pemphigus corticorésistant traité avec succès par immunoglobulines intraveineuses. Ann Dermatol Venereol 2000;127:408-10.
15. Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999;140:865-74.
16. Colonna L, Cianchini G, Frezzolini A, De Pita O, Di Lella G, Puddu P. Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy? Br J Dermatol 1998;138:1102-3.
17. Wever S, Zillikens D, Brocker EB. Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy. Br J Dermatol 1996;135:862-3.
18. Bewley AP, Keefe M. Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy. Br J Dermatol 1996;135:128-9.
19. Beckers RC, Brand A, Vermeer BJ, Boom BW. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol 1995;133:289-93.
20. Messer G, Sizmann N, Feucht H, Meurer M. High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. Br J Dermatol 1995;133:1014-6.
21. Sami N, Bhol K, Ahmed R. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris. Eur J Dermatol 2003;13:377-81
22. Dehen L, Crickx B, Grossin M, Belaich S. Etude comparative de l'évolution et du pronostic des pemphigus vulgaire et séborrhéique. Ann Dermatol Venereol 1993;120:874-8.
23. Bhol KC, Desai A, Kumari S, Colon J E, Ahmed AR. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol 2001;100:172-80.
24. Kazatchkine M, Kaveri S. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
25. Jegou R, Mourtada I, Ollivier I, Chevrant-Breton J. Effets secondaires des traitements par immunoglobulines intraveineuses. Ann Dermatol Venereol 2001;128:786-91.